Homepage
What We Do
Conduct Research
Analyze and publish data related to coverage and the costs of obesity, including direct medical and employer-borne costs, but also those related to stigma and bias that impact quality of care.
Research
LEARN MORE ABOUT WHAT WE DO
Now Available:
STOP Obesity Alliance
2021 Annual Report
Stay Connected
Sign up for our monthly E‑newsletter
Subscribe below to receive STOP's monthly email packed with insights from experts in obesity prevention and treatment, details on upcoming events, and exciting news from our member organizations!
Recently from the Director
The Roundtable on Obesity Solutions, established by the Institute of Medicine (IOM, now the Health and Medicine Division of the National Academies of Sciences, Engineering, and Medicine) in 2014, followed 8 years of the IOM’s engagement with obesity.
A recent updated guidance sent to health insurance carriers that administer the Federal Employee Health Benefit (FEHB) has clarified that “carriers are not allowed to exclude anti-obesity medications from coverage based on a benefit exclusion or a carve out." This guidance is encouraging and should help in our efforts to increase the number of h
